July 3, 2023 On June 8, 2023, the United States Supreme Court issued a unanimous decision in United States v. Dubin and blunted the government’s overly expansive use of the… Read more »
May 17, 2023 On May 9, 2023, just before the expiration of the COVID-19 Public Health Emergency (“PHE”), the Drug Enforcement Administration (“DEA”) extended a policy permitting the prescription of… Read more »
May 1, 2023 On March 31, a Connecticut trial court upheld privilege afforded to Patient Safety Work Product (“PSWP”) in what is believed to be the state’s first reported opinion… Read more »
April 28, 2023 The Centers for Medicare and Medicaid (CMS) have kept true to their commitment to focus on hospital price transparency in 2023 again yesterday announcing plans to strengthen… Read more »
April 28, 2023 On April 21, 2023, the United States Supreme Court settled almost a month-long dispute regarding the current status of mifepristone prescriptions. Specifically, the Court granted a stay… Read more »
April 19, 2023 On Friday, April 14, 2023, The United States Attorney’s Office for the Eastern District of Virginia announced that it sent a Dear Colleagues Letter to remind healthcare… Read more »
March 2, 2023 This Spring, the Florida Supreme Court will again review the intersection between the Patient Safety and Quality Improvement Act of 2005 (“PSQIA”) and Florida’s Amendment 7, the… Read more »
February 3, 2023 On January 30, 2023, President Biden announced his administration’s intent to end the COVID-19 Public Health Emergency (“PHE”) effective May 11, 2023. This change will impact providers… Read more »
January 10, 2023 On January 5, 2023, the Federal Trade Commission (“FTC”) proposed a sweeping rule that, if enacted as initially drafted, will prohibit employers from entering into or enforcing… Read more »
November 8, 2022 While 2022 is winding down, the Centers for Medicare and Medicaid Services (CMS) and the Office of Inspector General (OIG) are gearing up for 2023 compliance monitoring,… Read more »
